VTE/PE Prophylaxis and Treatment:
An Urgent Call to Action for a Common, Preventable Disease

A CME Webcast and Podcast

Date of Release: 2-15-2008           Termination Date: 2-15-2009

Estimated time to complete: 1 hour

Up to 1 AMA PRA Category 1 Credit™

This activity is part of a comprehensive CME initiative to improve the diagnosis and management of patients with or at risk for VTE/PE. This special on-demand Webcast explores evidence-based strategies for VTE prophylaxis and treatment. Join Dr. Pollack as he discusses the link between implementation of national guidelines for VTE/PE prevention and better patient outcomes and then assesses the currently available therapeutic strategies.

Faculty:

Charles V. Pollack, Jr MD, MA, FACEP
Professor of Emergency Medicine
University of Pennsylvania School of Medicine
Chairman, Department of Emergency Medicine
Pennsylvania Hospital
Philadelphia, Pennsylvania

ACCESS THE PROGRAM BY:

On-Demand Webcast

MP3 Audio

Podcast

Learning Objectives

After taking part in this activity, participants should be able to:

  • Describe the current treatment guidelines for prophylaxis and management of venous thromboembolism (VTE) and pulmonary embolism (PE) in the high-risk hospitalized patient, with well-established risk factors such as acute illness, cancer, and infection, and those who are undergoing a surgical procedure

  • Review the strengths and weaknesses of the data supporting individual guideline recommendations for the high-risk hospitalized patient

  • Assess currently available therapeutic strategies for patients at high risk of developing VTE

  • Explain the risks and benefits of individual treatment options as they pertain to different high-risk patient populations

This program is designed for hematologists, emergency medicine physicians, oncologists, surgeons, internists, and hospitalists.

Accreditation and Designation of Credit:

The Network for Continuing Medical Education (NCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

The Network for Continuing Medical Education requires that CME faculty disclose, during the planning of an activity, the existence of any personal financial or other relationships they or their spouses may have with the commercial supporter of the activity or with the manufacturer of any commercial product or service discussed in the activity.

Faculty Disclosures:

Charles V. Pollack, Jr MD, has served as a consultant to Genentech, Inc., Millennium Pharmaceuticals, Inc., and sanofi-aventis, and received honoraria from Genentech, Inc., sanofi-aventis, and Schering-Plough Corporation.

The NCME editorial team reports no such relationships.

Evaluation for Physicians
After participating, you may download an evaluation form for return via fax to 201-867-2149. For your convenience, the downloadable form is available as an Adobe Acrobat document (.pdf) or as a Microsoft Word document (.doc).

Adobe Acrobat File
Microsoft Word Document

To download and view a PDF file that contains the evaluation form, Adobe Reader is required. Adobe Reader is available free from the Adobe site.

This activity is provided by the Network for Continuing Medical Education (NCME).

It is supported by an educational grant from sanofi-aventis U.S. Inc.